Industry Research Reports
Home > Reports > Chemical & Material > Global Dibromocyanoacetamide (DBNPA) Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Dibromocyanoacetamide (DBNPA) Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-08-05
Pages: 142 Pages
Report ld: 4864906
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Dibromocyanoacetamide (DBNPA) market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Dibromocyanoacetamide (DBNPA) or 2,2-dibromo-3-nitrilopropionamide is a quick-kill biocide that easily hydrolyzes under both acidic and alkaline conditions. It is preferred for its instability in water as it quickly kills and then quickly degrades to form a number of products, depending on the conditions, including ammonia, bromide ions, dibromoacetonitrile, and dibromoacetic acid. DBNPA acts similar to the typical halogen biocides.
From a downstream perspective, Papermaking accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Dibromocyanoacetamide (DBNPA) leading manufacturers including Lanxess, Anhui Meisenbao, Heze Runxin Bio-technology, Shandong IRO Water Treatment, Shandong Yubin, Taicang Liyuan Chemical, Weifang Yukai Chemical, etc., dominate supply; the top five capture approximately % of global revenue, with Lanxess leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Dibromocyanoacetamide (DBNPA) market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Lanxess
- Anhui Meisenbao
- Heze Runxin Bio-technology
- Shandong IRO Water Treatment
- Shandong Yubin
- Taicang Liyuan Chemical
- Weifang Yukai Chemical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Purity ≥99%
- Purity <99%
Segment by Application
- Papermaking
- Water Treatment
- Pharmaceutical Intermediates
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Dibromocyanoacetamide (DBNPA) study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Dibromocyanoacetamide (DBNPA): Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Dibromocyanoacetamide (DBNPA) Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Purity ≥99%
1.2.3 Purity <99%
1.3 Market Segmentation by Application
1.3.1 Global Dibromocyanoacetamide (DBNPA) Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Papermaking
1.3.3 Water Treatment
1.3.4 Pharmaceutical Intermediates
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Dibromocyanoacetamide (DBNPA) Revenue Estimates and Forecasts 2020-2031
2.2 Global Dibromocyanoacetamide (DBNPA) Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Dibromocyanoacetamide (DBNPA) Sales Estimates and Forecasts 2020-2031
2.4 Global Dibromocyanoacetamide (DBNPA) Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Dibromocyanoacetamide (DBNPA) Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 Europe
3.4.2 China
4 Competition by Manufacturers
4.1 Global Dibromocyanoacetamide (DBNPA) Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Dibromocyanoacetamide (DBNPA) Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Purity ≥99% Market Size by Manufacturers
4.5.2 Purity <99% Market Size by Manufacturers
4.6 Global Dibromocyanoacetamide (DBNPA) Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Dibromocyanoacetamide (DBNPA) Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Dibromocyanoacetamide (DBNPA) Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Dibromocyanoacetamide (DBNPA) Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Dibromocyanoacetamide (DBNPA) Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Dibromocyanoacetamide (DBNPA) Sales and Revenue by Type (2020-2031)
7.4 North America Dibromocyanoacetamide (DBNPA) Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Dibromocyanoacetamide (DBNPA) Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Dibromocyanoacetamide (DBNPA) Sales and Revenue by Type (2020-2031)
8.4 Europe Dibromocyanoacetamide (DBNPA) Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Dibromocyanoacetamide (DBNPA) Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Dibromocyanoacetamide (DBNPA) Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Dibromocyanoacetamide (DBNPA) Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Dibromocyanoacetamide (DBNPA) Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Dibromocyanoacetamide (DBNPA) Sales and Revenue by Type (2020-2031)
10.4 Central and South America Dibromocyanoacetamide (DBNPA) Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Dibromocyanoacetamide (DBNPA) Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Dibromocyanoacetamide (DBNPA) Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Dibromocyanoacetamide (DBNPA) Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Dibromocyanoacetamide (DBNPA) Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Lanxess
12.1.1 Lanxess Corporation Information
12.1.2 Lanxess Business Overview
12.1.3 Lanxess Dibromocyanoacetamide (DBNPA) Product Models, Descriptions and Specifications
12.1.4 Lanxess Dibromocyanoacetamide (DBNPA) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Lanxess Dibromocyanoacetamide (DBNPA) Sales by Product in 2024
12.1.6 Lanxess Dibromocyanoacetamide (DBNPA) Sales by Application in 2024
12.1.7 Lanxess Dibromocyanoacetamide (DBNPA) Sales by Geographic Area in 2024
12.1.8 Lanxess Dibromocyanoacetamide (DBNPA) SWOT Analysis
12.1.9 Lanxess Recent Developments
12.2 Anhui Meisenbao
12.2.1 Anhui Meisenbao Corporation Information
12.2.2 Anhui Meisenbao Business Overview
12.2.3 Anhui Meisenbao Dibromocyanoacetamide (DBNPA) Product Models, Descriptions and Specifications
12.2.4 Anhui Meisenbao Dibromocyanoacetamide (DBNPA) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Anhui Meisenbao Dibromocyanoacetamide (DBNPA) Sales by Product in 2024
12.2.6 Anhui Meisenbao Dibromocyanoacetamide (DBNPA) Sales by Application in 2024
12.2.7 Anhui Meisenbao Dibromocyanoacetamide (DBNPA) Sales by Geographic Area in 2024
12.2.8 Anhui Meisenbao Dibromocyanoacetamide (DBNPA) SWOT Analysis
12.2.9 Anhui Meisenbao Recent Developments
12.3 Heze Runxin Bio-technology
12.3.1 Heze Runxin Bio-technology Corporation Information
12.3.2 Heze Runxin Bio-technology Business Overview
12.3.3 Heze Runxin Bio-technology Dibromocyanoacetamide (DBNPA) Product Models, Descriptions and Specifications
12.3.4 Heze Runxin Bio-technology Dibromocyanoacetamide (DBNPA) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Heze Runxin Bio-technology Dibromocyanoacetamide (DBNPA) Sales by Product in 2024
12.3.6 Heze Runxin Bio-technology Dibromocyanoacetamide (DBNPA) Sales by Application in 2024
12.3.7 Heze Runxin Bio-technology Dibromocyanoacetamide (DBNPA) Sales by Geographic Area in 2024
12.3.8 Heze Runxin Bio-technology Dibromocyanoacetamide (DBNPA) SWOT Analysis
12.3.9 Heze Runxin Bio-technology Recent Developments
12.4 Shandong IRO Water Treatment
12.4.1 Shandong IRO Water Treatment Corporation Information
12.4.2 Shandong IRO Water Treatment Business Overview
12.4.3 Shandong IRO Water Treatment Dibromocyanoacetamide (DBNPA) Product Models, Descriptions and Specifications
12.4.4 Shandong IRO Water Treatment Dibromocyanoacetamide (DBNPA) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Shandong IRO Water Treatment Dibromocyanoacetamide (DBNPA) Sales by Product in 2024
12.4.6 Shandong IRO Water Treatment Dibromocyanoacetamide (DBNPA) Sales by Application in 2024
12.4.7 Shandong IRO Water Treatment Dibromocyanoacetamide (DBNPA) Sales by Geographic Area in 2024
12.4.8 Shandong IRO Water Treatment Dibromocyanoacetamide (DBNPA) SWOT Analysis
12.4.9 Shandong IRO Water Treatment Recent Developments
12.5 Shandong Yubin
12.5.1 Shandong Yubin Corporation Information
12.5.2 Shandong Yubin Business Overview
12.5.3 Shandong Yubin Dibromocyanoacetamide (DBNPA) Product Models, Descriptions and Specifications
12.5.4 Shandong Yubin Dibromocyanoacetamide (DBNPA) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Shandong Yubin Dibromocyanoacetamide (DBNPA) Sales by Product in 2024
12.5.6 Shandong Yubin Dibromocyanoacetamide (DBNPA) Sales by Application in 2024
12.5.7 Shandong Yubin Dibromocyanoacetamide (DBNPA) Sales by Geographic Area in 2024
12.5.8 Shandong Yubin Dibromocyanoacetamide (DBNPA) SWOT Analysis
12.5.9 Shandong Yubin Recent Developments
12.6 Taicang Liyuan Chemical
12.6.1 Taicang Liyuan Chemical Corporation Information
12.6.2 Taicang Liyuan Chemical Business Overview
12.6.3 Taicang Liyuan Chemical Dibromocyanoacetamide (DBNPA) Product Models, Descriptions and Specifications
12.6.4 Taicang Liyuan Chemical Dibromocyanoacetamide (DBNPA) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Taicang Liyuan Chemical Recent Developments
12.7 Weifang Yukai Chemical
12.7.1 Weifang Yukai Chemical Corporation Information
12.7.2 Weifang Yukai Chemical Business Overview
12.7.3 Weifang Yukai Chemical Dibromocyanoacetamide (DBNPA) Product Models, Descriptions and Specifications
12.7.4 Weifang Yukai Chemical Dibromocyanoacetamide (DBNPA) Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Weifang Yukai Chemical Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Dibromocyanoacetamide (DBNPA) Industry Chain
13.2 Dibromocyanoacetamide (DBNPA) Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Dibromocyanoacetamide (DBNPA) Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Dibromocyanoacetamide (DBNPA) Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Dibromocyanoacetamide (DBNPA) Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Dibromocyanoacetamide (DBNPA) Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Dibromocyanoacetamide (DBNPA) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Dibromocyanoacetamide (DBNPA) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Dibromocyanoacetamide (DBNPA) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Dibromocyanoacetamide (DBNPA) Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Dibromocyanoacetamide (DBNPA) Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Dibromocyanoacetamide (DBNPA) Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Dibromocyanoacetamide (DBNPA) Sales by Region (2020-2025) & (Tons)
Table 8. Global Dibromocyanoacetamide (DBNPA) Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Dibromocyanoacetamide (DBNPA) Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 11. Global Dibromocyanoacetamide (DBNPA) Production by Region (2020-2025) & (Tons)
Table 12. Global Dibromocyanoacetamide (DBNPA) Production by Region (2026-2031) & (Tons)
Table 13. Global Dibromocyanoacetamide (DBNPA) Sales by Manufacturers (2020-2025) & (Tons)
Table 14. Global Dibromocyanoacetamide (DBNPA) Sales Share by Manufacturers (2020-2025)
Table 15. Global Dibromocyanoacetamide (DBNPA) Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Dibromocyanoacetamide (DBNPA) Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Dibromocyanoacetamide (DBNPA) by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dibromocyanoacetamide (DBNPA) as of 2024)
Table 19. Global Dibromocyanoacetamide (DBNPA) Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Dibromocyanoacetamide (DBNPA) Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
Table 21. Key Manufacturers Dibromocyanoacetamide (DBNPA) Manufacturing Base and Headquarters
Table 22. Global Dibromocyanoacetamide (DBNPA) Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Dibromocyanoacetamide (DBNPA) Sales by Type (2020-2025) & (Tons)
Table 26. Global Dibromocyanoacetamide (DBNPA) Sales by Type (2026-2031) & (Tons)
Table 27. Global Dibromocyanoacetamide (DBNPA) Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Dibromocyanoacetamide (DBNPA) Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Dibromocyanoacetamide (DBNPA) ASP by Type (2020-2031) & (US$/Ton)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Dibromocyanoacetamide (DBNPA) Sales by Application (2020-2025) & (Tons)
Table 32. Global Dibromocyanoacetamide (DBNPA) Sales by Application (2026-2031) & (Tons)
Table 33. Dibromocyanoacetamide (DBNPA) High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Dibromocyanoacetamide (DBNPA) Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Dibromocyanoacetamide (DBNPA) Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Dibromocyanoacetamide (DBNPA) ASP by Application (2020-2031) & (US$/Ton)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Dibromocyanoacetamide (DBNPA) Growth Accelerators and Market Barriers
Table 40. North America Dibromocyanoacetamide (DBNPA) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Dibromocyanoacetamide (DBNPA) Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Dibromocyanoacetamide (DBNPA) Growth Accelerators and Market Barriers
Table 43. Europe Dibromocyanoacetamide (DBNPA) Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Dibromocyanoacetamide (DBNPA) Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Dibromocyanoacetamide (DBNPA) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Dibromocyanoacetamide (DBNPA) Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Dibromocyanoacetamide (DBNPA) Growth Accelerators and Market Barriers
Table 48. Southeast Asia Dibromocyanoacetamide (DBNPA) Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Dibromocyanoacetamide (DBNPA) Investment Opportunities and Key Challenges
Table 50. Central and South America Dibromocyanoacetamide (DBNPA) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Dibromocyanoacetamide (DBNPA) Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Dibromocyanoacetamide (DBNPA) Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Lanxess Corporation Information
Table 54. Lanxess Description and Major Businesses
Table 55. Lanxess Product Models, Descriptions and Specifications
Table 56. Lanxess Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 57. Lanxess Sales Value Proportion by Product in 2024
Table 58. Lanxess Sales Value Proportion by Application in 2024
Table 59. Lanxess Sales Value Proportion by Geographic Area in 2024
Table 60. Lanxess Dibromocyanoacetamide (DBNPA) SWOT Analysis
Table 61. Lanxess Recent Developments
Table 62. Anhui Meisenbao Corporation Information
Table 63. Anhui Meisenbao Description and Major Businesses
Table 64. Anhui Meisenbao Product Models, Descriptions and Specifications
Table 65. Anhui Meisenbao Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 66. Anhui Meisenbao Sales Value Proportion by Product in 2024
Table 67. Anhui Meisenbao Sales Value Proportion by Application in 2024
Table 68. Anhui Meisenbao Sales Value Proportion by Geographic Area in 2024
Table 69. Anhui Meisenbao Dibromocyanoacetamide (DBNPA) SWOT Analysis
Table 70. Anhui Meisenbao Recent Developments
Table 71. Heze Runxin Bio-technology Corporation Information
Table 72. Heze Runxin Bio-technology Description and Major Businesses
Table 73. Heze Runxin Bio-technology Product Models, Descriptions and Specifications
Table 74. Heze Runxin Bio-technology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Heze Runxin Bio-technology Sales Value Proportion by Product in 2024
Table 76. Heze Runxin Bio-technology Sales Value Proportion by Application in 2024
Table 77. Heze Runxin Bio-technology Sales Value Proportion by Geographic Area in 2024
Table 78. Heze Runxin Bio-technology Dibromocyanoacetamide (DBNPA) SWOT Analysis
Table 79. Heze Runxin Bio-technology Recent Developments
Table 80. Shandong IRO Water Treatment Corporation Information
Table 81. Shandong IRO Water Treatment Description and Major Businesses
Table 82. Shandong IRO Water Treatment Product Models, Descriptions and Specifications
Table 83. Shandong IRO Water Treatment Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 84. Shandong IRO Water Treatment Sales Value Proportion by Product in 2024
Table 85. Shandong IRO Water Treatment Sales Value Proportion by Application in 2024
Table 86. Shandong IRO Water Treatment Sales Value Proportion by Geographic Area in 2024
Table 87. Shandong IRO Water Treatment Dibromocyanoacetamide (DBNPA) SWOT Analysis
Table 88. Shandong IRO Water Treatment Recent Developments
Table 89. Shandong Yubin Corporation Information
Table 90. Shandong Yubin Description and Major Businesses
Table 91. Shandong Yubin Product Models, Descriptions and Specifications
Table 92. Shandong Yubin Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Shandong Yubin Sales Value Proportion by Product in 2024
Table 94. Shandong Yubin Sales Value Proportion by Application in 2024
Table 95. Shandong Yubin Sales Value Proportion by Geographic Area in 2024
Table 96. Shandong Yubin Dibromocyanoacetamide (DBNPA) SWOT Analysis
Table 97. Shandong Yubin Recent Developments
Table 98. Taicang Liyuan Chemical Corporation Information
Table 99. Taicang Liyuan Chemical Description and Major Businesses
Table 100. Taicang Liyuan Chemical Product Models, Descriptions and Specifications
Table 101. Taicang Liyuan Chemical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 102. Taicang Liyuan Chemical Recent Developments
Table 103. Weifang Yukai Chemical Corporation Information
Table 104. Weifang Yukai Chemical Description and Major Businesses
Table 105. Weifang Yukai Chemical Product Models, Descriptions and Specifications
Table 106. Weifang Yukai Chemical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 107. Weifang Yukai Chemical Recent Developments
Table 108. Key Raw Materials Distribution
Table 109. Raw Materials Key Suppliers
Table 110. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 111. Milestones in Production Technology Evolution
Table 112. Distributors List
Table 113. Market Trends and Market Evolution
Table 114. Market Drivers and Opportunities
Table 115. Market Challenges, Risks, and Restraints
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Dibromocyanoacetamide (DBNPA) Product Picture
Figure 2. Global Dibromocyanoacetamide (DBNPA) Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Purity ≥99% Product Picture
Figure 4. Purity <99% Product Picture
Figure 5. Global Dibromocyanoacetamide (DBNPA) Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Papermaking
Figure 7. Water Treatment
Figure 8. Pharmaceutical Intermediates
Figure 9. Others
Figure 10. Dibromocyanoacetamide (DBNPA) Report Years Considered
Figure 11. Global Dibromocyanoacetamide (DBNPA) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Dibromocyanoacetamide (DBNPA) Revenue (2020-2031) & (US$ Million)
Figure 13. Global Dibromocyanoacetamide (DBNPA) Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Dibromocyanoacetamide (DBNPA) Revenue Market Share by Region (2020-2031)
Figure 15. Global Dibromocyanoacetamide (DBNPA) Sales (2020-2031) & (Tons)
Figure 16. Global Dibromocyanoacetamide (DBNPA) Sales (CAGR) by Region (2020-2031) (Tons)
Figure 17. Global Dibromocyanoacetamide (DBNPA) Sales Market Share by Region (2020-2031)
Figure 18. Global Dibromocyanoacetamide (DBNPA) Capacity, Production and Utilization (2020-2031) & (Tons)
Figure 19. Global Dibromocyanoacetamide (DBNPA) Production Trend by Region (2020-2031) (Tons)
Figure 20. Global Dibromocyanoacetamide (DBNPA) Production Market Share by Region (2020-2031)
Figure 21. Production Capacity Enablers & Constraints
Figure 22. Dibromocyanoacetamide (DBNPA) Production Growth Rate in Europe (2020-2031) & (Tons)
Figure 23. Dibromocyanoacetamide (DBNPA) Production Growth Rate in China (2020-2031) & (Tons)
Figure 24. Top 5 and Top 10 Manufacturers Dibromocyanoacetamide (DBNPA) Sales Volume Market Share in 2024
Figure 25. Global Dibromocyanoacetamide (DBNPA) Revenue Market Share Ranking (2024)
Figure 26. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 27. Purity ≥99% Revenue Market Share by Manufacturer in 2024
Figure 28. Purity <99% Revenue Market Share by Manufacturer in 2024
Figure 29. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 30. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 31. Global Dibromocyanoacetamide (DBNPA) Sales Market Share by Type (2020-2031)
Figure 32. Global Dibromocyanoacetamide (DBNPA) Revenue Market Share by Type (2020-2031)
Figure 33. Global Dibromocyanoacetamide (DBNPA) Sales Market Share by Application (2020-2031)
Figure 34. Global Dibromocyanoacetamide (DBNPA) Revenue Market Share by Application (2020-2031)
Figure 35. North America Dibromocyanoacetamide (DBNPA) Sales YoY (2020-2031) & (Tons)
Figure 36. North America Dibromocyanoacetamide (DBNPA) Revenue YoY (2020-2031) & (US$ Million)
Figure 37. North America Top 5 Manufacturers Dibromocyanoacetamide (DBNPA) Sales Revenue (US$ Million) in 2024
Figure 38. North America Dibromocyanoacetamide (DBNPA) Sales Volume (Tons) by Type (2020- 2031)
Figure 39. North America Dibromocyanoacetamide (DBNPA) Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 40. North America Dibromocyanoacetamide (DBNPA) Sales Volume (Tons) by Application (2020-2031)
Figure 41. North America Dibromocyanoacetamide (DBNPA) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 42. US Dibromocyanoacetamide (DBNPA) Revenue (2020-2031) & (US$ Million)
Figure 43. Canada Dibromocyanoacetamide (DBNPA) Revenue (2020-2031) & (US$ Million)
Figure 44. Mexico Dibromocyanoacetamide (DBNPA) Revenue (2020-2031) & (US$ Million)
Figure 45. Europe Dibromocyanoacetamide (DBNPA) Sales YoY (2020-2031) & (Tons)
Figure 46. Europe Dibromocyanoacetamide (DBNPA) Revenue YoY (2020-2031) & (US$ Million)
Figure 47. Europe Top 5 Manufacturers Dibromocyanoacetamide (DBNPA) Sales Revenue (US$ Million) in 2024
Figure 48. Europe Dibromocyanoacetamide (DBNPA) Sales Volume (Tons) by Type (2020-2031)
Figure 49. Europe Dibromocyanoacetamide (DBNPA) Sales Revenue (US$ Million) by Type (2020-2031)
Figure 50. Europe Dibromocyanoacetamide (DBNPA) Sales Volume (Tons) by Application (2020-2031)
Figure 51. Europe Dibromocyanoacetamide (DBNPA) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 52. Germany Dibromocyanoacetamide (DBNPA) Revenue (2020-2031) & (US$ Million)
Figure 53. France Dibromocyanoacetamide (DBNPA) Revenue (2020-2031) & (US$ Million)
Figure 54. U.K. Dibromocyanoacetamide (DBNPA) Revenue (2020-2031) & (US$ Million)
Figure 55. Italy Dibromocyanoacetamide (DBNPA) Revenue (2020-2031) & (US$ Million)
Figure 56. Russia Dibromocyanoacetamide (DBNPA) Revenue (2020-2031) & (US$ Million)
Figure 57. Asia-Pacific Dibromocyanoacetamide (DBNPA) Sales YoY (2020-2031) & (Tons)
Figure 58. Asia-Pacific Dibromocyanoacetamide (DBNPA) Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Asia-Pacific Top 8 Manufacturers Dibromocyanoacetamide (DBNPA) Sales Revenue (US$ Million) in 2024
Figure 60. Asia-Pacific Dibromocyanoacetamide (DBNPA) Sales Volume (Tons) by Type (2020- 2031)
Figure 61. Asia-Pacific Dibromocyanoacetamide (DBNPA) Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 62. Asia-Pacific Dibromocyanoacetamide (DBNPA) Sales Volume (Tons) by Application (2020-2031)
Figure 63. Asia-Pacific Dibromocyanoacetamide (DBNPA) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 64. Indonesia Dibromocyanoacetamide (DBNPA) Revenue (2020-2031) & (US$ Million)
Figure 65. Japan Dibromocyanoacetamide (DBNPA) Revenue (2020-2031) & (US$ Million)
Figure 66. South Korea Dibromocyanoacetamide (DBNPA) Revenue (2020-2031) & (US$ Million)
Figure 67. China Taiwan Dibromocyanoacetamide (DBNPA) Revenue (2020-2031) & (US$ Million)
Figure 68. India Dibromocyanoacetamide (DBNPA) Revenue (2020-2031) & (US$ Million)
Figure 69. Central and South America Dibromocyanoacetamide (DBNPA) Sales YoY (2020-2031) & (Tons)
Figure 70. Central and South America Dibromocyanoacetamide (DBNPA) Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Central and South America Top 5 Manufacturers Dibromocyanoacetamide (DBNPA) Sales Revenue (US$ Million) in 2024
Figure 72. Central and South America Dibromocyanoacetamide (DBNPA) Sales Volume (Tons) by Type (2021-2031)
Figure 73. Central and South America Dibromocyanoacetamide (DBNPA) Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Central and South America Dibromocyanoacetamide (DBNPA) Sales Volume (Tons) by Application (2020-2031)
Figure 75. Central and South America Dibromocyanoacetamide (DBNPA) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. Brazil Dibromocyanoacetamide (DBNPA) Revenue (2020-2025) & (US$ Million)
Figure 77. Argentina Dibromocyanoacetamide (DBNPA) Revenue (2020-2025) & (US$ Million)
Figure 78. Middle East, and Africa Dibromocyanoacetamide (DBNPA) Sales YoY (2020-2031) & (Tons)
Figure 79. Middle East and Africa Dibromocyanoacetamide (DBNPA) Revenue YoY (2020-2031) & (US$ Million)
Figure 80. Middle East and Africa Top 5 Manufacturers Dibromocyanoacetamide (DBNPA) Sales Revenue (US$ Million) in 2024
Figure 81. Middle East and Africa Dibromocyanoacetamide (DBNPA) Sales Volume (Tons) by Type (2021-2031)
Figure 82. South America Dibromocyanoacetamide (DBNPA) Sales Revenue (US$ Million) by Type (2020-2031)
Figure 83. Middle East and Africa Dibromocyanoacetamide (DBNPA) Sales Volume (Tons) by Application (2020-2031)
Figure 84. Middle East and Africa Dibromocyanoacetamide (DBNPA) Sales Revenue (US$ Million) by Application (2020-2031)
Figure 85. GCC Countries Dibromocyanoacetamide (DBNPA) Revenue (2020-2025) & (US$ Million)
Figure 86. Turkey Dibromocyanoacetamide (DBNPA) Revenue (2020-2025) & (US$ Million)
Figure 87. Egypt Dibromocyanoacetamide (DBNPA) Revenue (2020-2025) & (US$ Million)
Figure 88. South Africa Dibromocyanoacetamide (DBNPA) Revenue (2020-2025) & (US$ Million)
Figure 89. Dibromocyanoacetamide (DBNPA) Industry Chain Mapping
Figure 90. Regional Dibromocyanoacetamide (DBNPA) Manufacturing Base Distribution (%)
Figure 91. Dibromocyanoacetamide (DBNPA) Production Process
Figure 92. Regional Dibromocyanoacetamide (DBNPA) Production Cost Structure
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Dibromocyanoacetamide (DBNPA) market?
The top companies in the global Dibromocyanoacetamide (DBNPA) market are Lanxess、Anhui Meisenbao、Heze Runxin Bio-technology.
Related Reports
Global Dibromocyanoacetamide (DBNPA) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Dibromocyanoacetamide (DBNPA) market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 138
USD 4900.00
(Single User License)
Global Dibromocyanoacetamide (DBNPA) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Dibromocyanoacetamide (DBNPA) market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 77
USD 4250.00
(Single User License)
Global Dibromocyanoacetamide (DBNPA) Market Research Report 2026
The global Dibromocyanoacetamide (DBNPA) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 128
USD 2900.00
(Single User License)
Dibromocyanoacetamide (DBNPA)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Dibromocyanoacetamide (DBNPA) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 106
USD 3950.00
(Single User License)
Dibromocyanoacetamide (DBNPA) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Dibromocyanoacetamide (DBNPA) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-13
Pages: 107
USD 3950.00
(Single User License)
Global Dibromocyanoacetamide (DBNPA) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Dibromocyanoacetamide (DBNPA) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 78
USD 4250.00
(Single User License)
Global Dibromocyanoacetamide (DBNPA) Market Research Report 2025
The global market for Dibromocyanoacetamide (DBNPA) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 86
USD 2900.00
(Single User License)
Global Dibromocyanoacetamide (DBNPA) Market Research Report 2024
Dibromocyanoacetamide (DBNPA) or 2,2-dibromo-3-nitrilopropionamide is a quick-kill biocide that easily hydrolyzes under both acidic and alkaline conditions. It is preferred for its instability in water as it quickly kills and then quickly degrades to form a number of products, depending on the conditions, including ammonia, bromide ions, dibromoacetonitrile, and dibromoacetic acid. DBNPA acts similar to the typical halogen biocides.
Published Date: 2024-08-17
Pages: 94
USD 2900.00
(Single User License)
Global and China Dibromocyanoacetamide (DBNPA) Market Report & Forecast 2024-2030
Dibromocyanoacetamide (DBNPA) or 2,2-dibromo-3-nitrilopropionamide is a quick-kill biocide that easily hydrolyzes under both acidic and alkaline conditions. It is preferred for its instability in water as it quickly kills and then quickly degrades to form a number of products, depending on the conditions, including ammonia, bromide ions, dibromoacetonitrile, and dibromoacetic acid. DBNPA acts similar to the typical halogen biocides.
Published Date: 2024-08-17
Pages: 117
USD 4350.00
(Single User License)
Global Dibromocyanoacetamide (DBNPA) Market Insights, Forecast to 2030
Dibromocyanoacetamide (DBNPA) or 2,2-dibromo-3-nitrilopropionamide is a quick-kill biocide that easily hydrolyzes under both acidic and alkaline conditions. It is preferred for its instability in water as it quickly kills and then quickly degrades to form a number of products, depending on the conditions, including ammonia, bromide ions, dibromoacetonitrile, and dibromoacetic acid. DBNPA acts similar to the typical halogen biocides.
Published Date: 2024-08-17
Pages: 134
USD 4900.00
(Single User License)
Global Dibromocyanoacetamide (DBNPA) Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Dibromocyanoacetamide (DBNPA) market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 138
USD 4900.00 (Single User License)Global Dibromocyanoacetamide (DBNPA) Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Dibromocyanoacetamide (DBNPA) market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 77
USD 4250.00 (Single User License)Global Dibromocyanoacetamide (DBNPA) Market Research Report 2026
The global Dibromocyanoacetamide (DBNPA) market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 128
USD 2900.00 (Single User License)Dibromocyanoacetamide (DBNPA)- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Dibromocyanoacetamide (DBNPA) was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 106
USD 3950.00 (Single User License)Dibromocyanoacetamide (DBNPA) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Dibromocyanoacetamide (DBNPA) was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-13
Pages: 107
USD 3950.00 (Single User License)Global Dibromocyanoacetamide (DBNPA) Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Dibromocyanoacetamide (DBNPA) market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 78
USD 4250.00 (Single User License)Global Dibromocyanoacetamide (DBNPA) Market Research Report 2025
The global market for Dibromocyanoacetamide (DBNPA) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 86
USD 2900.00 (Single User License)Global Dibromocyanoacetamide (DBNPA) Market Research Report 2024
Dibromocyanoacetamide (DBNPA) or 2,2-dibromo-3-nitrilopropionamide is a quick-kill biocide that easily hydrolyzes under both acidic and alkaline conditions. It is preferred for its instability in water as it quickly kills and then quickly degrades to form a number of products, depending on the conditions, including ammonia, bromide ions, dibromoacetonitrile, and dibromoacetic acid. DBNPA acts similar to the typical halogen biocides.
Published: 2024-08-17
Pages: 94
USD 2900.00 (Single User License)Global and China Dibromocyanoacetamide (DBNPA) Market Report & Forecast 2024-2030
Dibromocyanoacetamide (DBNPA) or 2,2-dibromo-3-nitrilopropionamide is a quick-kill biocide that easily hydrolyzes under both acidic and alkaline conditions. It is preferred for its instability in water as it quickly kills and then quickly degrades to form a number of products, depending on the conditions, including ammonia, bromide ions, dibromoacetonitrile, and dibromoacetic acid. DBNPA acts similar to the typical halogen biocides.
Published: 2024-08-17
Pages: 117
USD 4350.00 (Single User License)Global Dibromocyanoacetamide (DBNPA) Market Insights, Forecast to 2030
Dibromocyanoacetamide (DBNPA) or 2,2-dibromo-3-nitrilopropionamide is a quick-kill biocide that easily hydrolyzes under both acidic and alkaline conditions. It is preferred for its instability in water as it quickly kills and then quickly degrades to form a number of products, depending on the conditions, including ammonia, bromide ions, dibromoacetonitrile, and dibromoacetic acid. DBNPA acts similar to the typical halogen biocides.
Published: 2024-08-17
Pages: 134
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now